We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/3/2019 16:52 | Read the latest tweet, article in the Scottish Herald. Statement from Colin King reference turnover... | barrywhit | |
07/3/2019 14:23 | They could be filling an order for the new Non-Exec Director, just surprised the lack of buying after the CD4 update.... | barrywhit | |
07/3/2019 10:26 | I am surprised that there are still sellers.. My concern is that this is being manipulated down. I have done a small trade . The price is currently 12 to sell and 13 to buy. Could be a fund raise on the way. Alternatively a takeover . Which I have mentioned before. Does anyone have any constructive thoughts on this. | upomega | |
06/3/2019 09:55 | INMO Excellent news and congratulations to Colin King and his team. Everything that they have said they would do during the past year has so far materialised . | upomega | |
06/3/2019 08:45 | Not concerned, or surprised, at lack of market reaction thus far. This will be a slow burner now in all likelihood. But I am now bullish again. The worst is over. | dibs61 | |
06/3/2019 08:41 | Good to see that they are one step further in Visitect commercialisation. The only note of caution comes with the statement: "As expected by the Company, the order quantities are low at this stage and reflect distributors' intentions to seed their private business-to-business market channels in the initial stages"I might be tempted back soon.I | longshanks | |
06/3/2019 08:34 | Literally, no interest from the market. Shareholders have lost trust in these guys. | likitorma | |
06/3/2019 07:52 | Well if today's news is anything to go by we could be in for some major orders by the end of the year. I certainly think it would be daft to sell at this price at this stage. | arthur_lame_stocks | |
06/3/2019 07:42 | Getting there slowly... | barrywhit | |
06/3/2019 07:08 | Very positive CD4 update! 👏 | hyperboreus | |
05/3/2019 17:10 | People seem to be selling despite the recent positive news communicated.I have mentioned this before, but it would be interesting to see how much stock is now held by p,i,s | upomega | |
04/3/2019 17:18 | I understood that we should hopefully have some orders re visetect around now. It was mentioned by the CEO in an article in either the Scotsman or Scotish Herald back in December. So fingers crossed | upomega | |
04/3/2019 14:46 | Hi p1nkfish, very well thanks, hope you and yours are all well. We could really do with a good bit of news to lift the share price. | barrywhit | |
01/3/2019 22:00 | Hope all is well barry. Sneller keeping it close, wonder what they could possibly talk about when they meet up at family gatherings. | p1nkfish | |
01/3/2019 17:01 | A few more tweets from omega including this tweet from IDS. IDS are pleased to announce the launch of the #Allergy panel on the IDS-iSYS Multi-Discipline Automated System. @OmegaDiagnostic, our partner, are developing a range of allergens and have appointed IDS as an exclusive, global distributor. Also a tweet showing a photo of our new NON-EXEC Director........LOL | barrywhit | |
01/3/2019 11:17 | Yes the pressure is growing to deliver near term shareholder value. Anyone aware when we might expect to receive WHO approval for Visitect CD4 bulk orders for NGO’s? | dibs61 | |
01/3/2019 08:20 | Sneller's boots are getting worryingly close to the board's backside! | likitorma | |
01/3/2019 08:10 | They have been looking for another NON-EXEC Director since before December, it just happens to be Sneller's Brother in Law....LOL | barrywhit | |
01/3/2019 07:49 | Hope they have the stupid pay packages that the board is on in mind. Let's see that trimmed by Sneller's BIL once he is appointed to remuneration board. | likitorma | |
01/3/2019 07:22 | Seems like Sneller has lost trust in the board and parachuted in his sister's partner. | likitorma | |
01/3/2019 07:19 | RNS - New Non Exec Director ....Interesting: Mr Jeremy Howard Millard, age 47, is the brother-in-law of Richard Sneller, who has a substantial shareholding in the Company. Lets hope he picks up some stock.. | barrywhit | |
01/3/2019 07:19 | Obviously independent then!!! | arthur_lame_stocks | |
01/3/2019 07:15 | Interesting board appointment announced today considering 'Mr Jeremy Howard Millard, age 47, is the brother-in-law of Richard Sneller, who has a substantial shareholding in the Company.' | hyperboreus | |
01/3/2019 06:52 | Bomber, those are quite juicy numbers. The issue is whether the board will actually deliver on the promises. Can buy at bid price (13p) suggesting this has further to fall, unfortunately. | likitorma | |
27/2/2019 22:40 | Thanks bomber | upomega |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions